South America Ultrasound Devices Market Analysis by Mordor Intelligence
The South America Ultrasound Devices Market size is estimated at USD 513.57 million in 2025, and is expected to reach USD 597.39 million by 2030, at a CAGR of 3.07% during the forecast period (2025-2030).
Current growth is driven by wider reimbursement coverage, rising non-communicable diseases, and the steady roll-out of AI-enabled and wireless systems that improve workflow efficiency and expand access. Brazil continues to anchor the South America ultrasound devices market through a large installed base, while Argentina is setting the growth pace as public and private investment modernizes imaging infrastructure. Portable models are penetrating secondary cities, addressing physician shortages and catalyzing wider usage across point-of-care settings. High-intensity focused ultrasound (HIFU) is gaining traction as an adjunct therapy in oncology, stimulating incremental demand for next-generation platforms.
Key Report Takeaways
- By application, radiology held 26.81% of the South America ultrasound devices market share in 2024, while anesthesiology is forecast to post a 4.97% CAGR through 2030.
- By technology, 3D/4D imaging commanded 47.27% of the South America ultrasound devices market size in 2024; HIFU is projected to expand at a 5.15% CAGR between 2025-2030.
- By portability, stationary systems accounted for 71.48% of the South America ultrasound devices market size in 2024, whereas the hand-held/pocket segment is advancing at a 7.28% CAGR to 2030.
- By end user, hospitals and surgical centers controlled 58.14% of the South America ultrasound devices market size in 2024, and ambulatory care centers are on track for a 6.56% CAGR during 2025-2030.
- By country, Brazil captured 48.92% revenue share of the South America ultrasound devices market in 2024, and Argentina is forecast to deliver a 4.08% CAGR to 2030.
South America Ultrasound Devices Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Expansion of imaging reimbursement | +0.8% | Brazil, Argentina, Colombia | Medium term (2-4 years) |
| Escalating non-communicable disease burden | +1.0% | All South America; highest in Brazil | Long term (≥4 years) |
| Adoption of AI-enabled & wireless solutions | +1.2% | Brazil, Chile, Colombia | Short term (≤2 years) |
| Government and private funding for R&D | +0.5% | Brazil, Argentina | Medium term (2-4 years) |
| Rising cancer incidence driving demand for radiation-free imaging | +0.7% | Colombia, Argentina | Long term (≥4 years) |
| Growth in portable & telemedicine-integrated ultrasound devices | +0.9% | Secondary cities across South America | Short term (≤2 years) |
| Source: Mordor Intelligence | |||
Expansion of Imaging Reimbursement Boosting Ultrasound Adoption
Broader reimbursement schemes are strengthening the South America ultrasound devices market by lowering out-of-pocket costs for patients and supporting provider economics. Brazil’s Medicare now reimburses an average USD 17,500 for histotripsy therapy, encouraging hospitals to procure high-end HIFU systems. Argentina added carotid and femoral ultrasound to preventive screening, revealing carotid plaques in 51% of asymptomatic adults, which underscores early detection value. Colombia extended telemedicine reimbursement to remote ultrasound interpretation, with 86% of facilities using ICTs for maternal care, fueling demand for cloud-connected probes.[1]Eduardo Capasso et al., “ICT Use in Maternal Care Facilities,” who.int These policy shifts reinforce supplier incentives to align product portfolios with reimbursed procedures. Healthy reimbursement further alleviates margin pressure for providers operating in cash-limited public systems.
Escalating Non-Communicable Disease Burden Driving Demand for Cardiac & Abdominal Ultrasound
Non-communicable diseases remain the largest mortality contributor in the region and elevate routine imaging needs. Colombia recorded 117,620 new cancer cases in 2024, accelerating uptake of real-time ultrasound for tumor staging and guidance. Vascular ultrasound studies in Argentina detected subclinical carotid plaques in more than half of tested adults, signifying a silent surge in atherosclerosis. Brazil’s elderly population is set to reach 37.8% by 2070, and life expectancy could climb to 83.9 years, broadening chronic disease management workloads. Continuous imaging underpins timely intervention, particularly for cardiac, abdominal, and vascular assessments. Consequently, hospitals are enlarging their ultrasound fleets while outpatient centers focus on portable devices for routine follow-up.
Adoption of AI-Enabled & Wireless Ultrasound Solutions Enhancing Workflow Efficiency
AI algorithms now automate fetal measurements and improve organ segmentation, reducing scan times by up to 40% on devices such as GE HealthCare’s Voluson Signature.[2]“Voluson Signature Launch,” gehealthcare.com Workflow acceleration helps mitigate shortages of certified sonographers, a major obstacle outside capital cities. Wireless probes integrate seamlessly with smartphones, fostering point-of-care use in ambulances and community clinics. AI-assisted interpretation expands the South America ultrasound devices market by enabling less-skilled personnel to conduct basic exams, while cloud connectivity supports specialist review. Rising connectivity in Chile and Colombia bolsters remote collaboration, accelerating decision-making and optimising resource allocation.
Government and Private Funding for R&D in Ultrasound Imaging
Policy makers recognise ultrasound’s cost advantage over CT or MRI and are channeling funds into next-generation systems. Argentina secured a USD 200 million Inter-American Development Bank loan in 2023 to enlarge diagnostic imaging coverage, directly benefiting public hospitals.[3]“Inter-American Development Bank Loan for Argentina Imaging,” iadb.org Venture investors committed USD 102 million to histotripsy developer HistoSonics, highlighting strong appetite for therapeutic ultrasound platforms. These inflows encourage collaboration between academia and suppliers, focusing on improved transducer materials, battery life, and AI firmware. Over the medium term, faster innovation cycles will broaden clinical indications and maintain pricing flexibility, reinforcing the South America ultrasound devices market growth trajectory.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Prolonged & divergent regulatory approval processes | -0.6% | All South America; strongest in smaller markets | Medium term (2-4 years) |
| Limited availability of certified sonographers and radiologists | -0.9% | Secondary cities across all countries | Long term (≥4 years) |
| High equipment costs & maintenance burden | -0.7% | Low-income regions across South America | Short term (≤2 years) |
| Limited access in remote & underserved regions | -0.5% | Rural areas in Andes and Amazon corridors | Long term (≥4 years) |
| Source: Mordor Intelligence | |||
Prolonged & Divergent Regulatory Approval Processes
Medical device firms face heterogeneous and often lengthy approval frameworks that slow product launches. Brazil’s ANVISA requires Class III and Class IV systems to obtain full registration and Brazil-Good Manufacturing Practice certificates, extending timelines by 5-6 months. Although 2024 regulations permit reliance on foreign approvals, discordant documentation rules across neighboring countries still impose added compliance cost. The constraint curbs initial market entrance for smaller innovators and prolongs access to the latest features, dampening the competitive intensity within the South America ultrasound devices market.
Limited Availability of Certified Sonographers and Radiologists in Secondary Cities
Specialist shortages limit service expansion beyond metropolitan hubs. The PROVAR+ echocardiography program in Brazil demonstrated that simplified protocols executed by nurses uncovered major heart disease in 29.2% of patients, signalling the hidden burden due to limited screening capacity. Rural hospitals often operate a single ultrasound unit staffed by rotating technicians, leading to long wait lists. This bottleneck can delay diagnoses, prompt patients to travel to urban centers, and constrain equipment utilisation rates, collectively tempering growth momentum in the South America ultrasound devices market.
Segment Analysis
By Application: Diagnostic Dominance Amid Accelerating Anesthesiology Growth
Radiology upheld supremacy in the South America ultrasound devices market with 26.81% share in 2024, backed by its integral role in multi-specialty diagnostics and the growing integration of AI-powered measurement tools. The South America ultrasound devices market size for radiology benefited from faster workflow, as seen with Siemens Acuson Sequoia 3.5 that automates organ labeling. Cardiology and gynecology/obstetrics remain sizable due to heightened screening, while critical care leverages point-of-care scanning for rapid triage.
Anesthesiology is projected to log a 4.97% CAGR through 2030, marking the quickest rise among applications. Wider uptake of ultrasound-guided nerve blocks improves procedural success and patient outcomes; Mindray’s regional anesthesia education series strengthens clinician proficiency. Hospital procurement teams now bundle portable probes with operating-room carts, sustaining momentum. Rising surgical volumes and enhanced patient safety protocols will continue to propel anesthesiology’s contribution to the South America ultrasound devices market.
Note: Segment shares of all individual segments available upon report purchase
By Technology: 3D/4D Lead as Therapeutic HIFU Accelerates
The 3D/4D technology tier captured 47.27% of the South America ultrasound devices market share in 2024, driven by superior volumetric clarity essential for fetal assessments and oncology staging. AI-enabled platforms like GE Voluson Signature 20 shorten second-trimester exams by 40%, underscoring efficiency gains. Conventional 2D remains relevant through AI-enhanced image optimisation, while Doppler supports cardiovascular evaluation.
HIFU systems will record a 5.15% CAGR to 2030, the fastest among technologies, buoyed by non-invasive tumor ablation success. Liver cancer histotripsy cases surpassing 300 globally demonstrate clinical acceptance. Expansion into prostate and uterine fibroid therapy will widen indications, adding momentum to the South America ultrasound devices market size growth for therapeutic platforms.
By Portability: Stationary Systems Retain Scale as Handheld Units Surge
Stationary consoles delivered 71.48% revenue in 2024 owing to comprehensive transducer arrays and full imaging suites required by tertiary hospitals. Acoustic Intelligence embedded in Mindray Resona A20 enhances diagnostic certainty, sustaining demand. Service agreements and upgrade pathways further entrench installed bases among large institutions.
Handheld/pocket models will progress at a 7.28% CAGR, more than double the overall market rate. Butterfly iQ3's lighter design and 3D capabilities resonate with emergency and primary-care clinicians. Cloud-based quality assurance aids training, compressing the skills gap. As procurement policies shift toward mobility, portable cart systems bridge functionality and transportability, reinforcing incremental adoption across the South America ultrasound devices market.
Note: Segment shares of all individual segments available upon report purchase
By End User: Hospital Leadership with Outpatient Momentum
Hospitals accounted for 58.14% of 2024 sales and continue to serve as reference sites for new product launches, including GE Versana Premier equipped with AI tools for multi-specialty workflows. Intensifying surgery throughput and the need for intraoperative guidance uphold console purchases.
Ambulatory care centres should clock a 6.56% CAGR to 2030 as cost-conscious payers steer procedures to outpatient settings. Compact and battery-operated units allow fast turnover and lower capital expenditure. Diagnostic imaging centres maintain volume for specialised exams, while physician offices and home-care programs gradually adopt mobile probes, extending market reach.
Geography Analysis
Brazil controlled 48.92% of the South America ultrasound devices market in 2024 underpinned by the continent’s largest healthcare budget and ongoing reimbursement expansion. ANVISA’s 2024 acceptance of foreign regulatory certificates trims approval timelines and encourages first-to-market launches. Tele-cardiology pilots like PROVAR+ illustrate remote reading feasibility, increasing utilisation across public clinics.
Argentina is forecast to achieve a 4.08% CAGR, benefiting from a USD 600 million credit line aimed at imaging upgrades. Prevalence of subclinical atherosclerosis revealed via vascular ultrasound highlights unmet need and supports volume growth. Chile and Colombia advance on the back of digital health readiness, with Colombia’s 86% ICT adoption in maternal care underpinning tele-ultrasound uptake.
Rest of South America, including Peru and Uruguay, exhibits sizeable whitespace for portable devices that bypass infrastructure constraints, while regulatory simplification could expedite entry in smaller markets. Steady urban migration and rising chronic disease prevalence ensure sustained demand, expanding the South America ultrasound devices market footprint across diverse economic contexts.
Competitive Landscape
The vendor landscape shows moderate concentration, dominated by global majors yet open to niche challengers. GE HealthCare enlarged its portfolio through the USD 51 million purchase of Intelligent Ultrasound in July 2024, reinforcing AI capabilities. Philips, Siemens Healthineers, and Samsung Medison invest heavily in ergonomic transducers and cloud ecosystems. Samsung’s acquisition of Sonio underlines an escalating focus on fetal AI.
Portable specialists Butterfly Network and Clarius Mobile Health target frontline clinicians with subscription-based imaging platforms. Partnerships such as Mindray–TeleRay integrate streaming to support remote interpretation and training. Emerging robotic solutions like FARUS automate thyroid scanning, hinting at future disruption that might reset competitive boundaries within the South America ultrasound devices market.
South America Ultrasound Devices Industry Leaders
-
GE HealthCare Technologies Inc.
-
Koninklijke Philips N.V.
-
Canon Medical Systems Corporation
-
FUJIFILM Holdings Corporation
-
Siemens Healthineers AG
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- May 2025: Mindray, a global leader in medical technology, is reinforcing its commitment to smart healthcare in South America through a high-impact showcase at Hospitalar, Brazil’s premier healthcare exhibition. Mindray unveiled Mindray’s TEX20 point-of-care ultrasound system, designed to deliver high-performance imaging in fast-paced clinical environments. The TEX20’s advanced imaging capabilities and portability make it especially relevant for Brazil’s expanding healthcare infrastructure, where accessibility and efficiency are top priorities.
- August 2024: SonoVascular, Inc. initiated a first-in-human (FIH) study for its SonoThrombectomy System, an innovative ultrasound-facilitated, thrombolytic-enhanced thrombectomy technology designed to treat venous thromboembolism with minimal blood loss. The initial procedure, successfully performed at Hospital DPIRECA in Santiago, Chile, demonstrated the system’s ability to effectively and safely remove thrombi while utilizing a reduced thrombolytic dosage. As ultrasound-based interventions gain traction in vascular treatments, this technological advancement is expected to drive the growth of the ultrasound devices market by broadening their applications in minimally invasive therapies.
- July 2024: Philips Foundation and SAS Brasil launched an innovation lab focused on digital health education. This initiative aims to enhance healthcare training in remote regions of Brazil by leveraging advanced ultrasound technology and telehealth solutions.
- July 2024: GE HealthCare acquired Intelligent Ultrasound for USD 51 million, enhancing its AI capabilities in ultrasound imaging and strengthening its competitive position in the growing AI-enabled ultrasound segment.
South America Ultrasound Devices Market Report Scope
Diagnostic ultrasound is an imaging technique that uses high-frequency sound waves to produce images of the different structures inside the body. These devices are utilized as both diagnostic imaging and therapeutic modality. They have a wide range of applications in the medical field.
The South America Ultrasound Devices Market is Segmented by Application (Anesthesiology, Cardiology, Gynecology/Obstetrics, Musculoskeletal, Radiology, Critical Care, and Other Applications), Technology (2D Ultrasound Imaging, 3D and 4D Ultrasound Imaging, Doppler Imaging, and High-intensity Focused Ultrasound), Type (Stationary Ultrasound and Portable Ultrasound), and Geography (Brazil, Argentina, and Rest of South America). The report offers the value (in USD million) for the above segments.
| Anesthesiology |
| Cardiology |
| Gynecology / Obstetrics |
| Musculoskeletal |
| Radiology |
| Critical Care |
| Other Applications |
| 2D Ultrasound Imaging |
| 3D & 4D Ultrasound Imaging |
| Doppler Imaging |
| High-intensity Focused Ultrasound (HIFU) |
| Other Technologies |
| Stationary Systems |
| Portable Cart-based Systems |
| Handheld / Wireless Systems |
| Hospitals & Surgical Centers |
| Diagnostic Imaging Centers |
| Ambulatory Care & Emergency Centers |
| Other End Users |
| Brazil |
| Argentina |
| Chile |
| Colombia |
| Rest of South America |
| By Application | Anesthesiology |
| Cardiology | |
| Gynecology / Obstetrics | |
| Musculoskeletal | |
| Radiology | |
| Critical Care | |
| Other Applications | |
| By Technology | 2D Ultrasound Imaging |
| 3D & 4D Ultrasound Imaging | |
| Doppler Imaging | |
| High-intensity Focused Ultrasound (HIFU) | |
| Other Technologies | |
| By Portability | Stationary Systems |
| Portable Cart-based Systems | |
| Handheld / Wireless Systems | |
| By End User | Hospitals & Surgical Centers |
| Diagnostic Imaging Centers | |
| Ambulatory Care & Emergency Centers | |
| Other End Users | |
| By Country | Brazil |
| Argentina | |
| Chile | |
| Colombia | |
| Rest of South America |
Key Questions Answered in the Report
What is the current size of the South America ultrasound devices market?
The South America ultrasound devices market size is USD 513.57 million in 2025 and is projected to reach USD 597.39 million by 2030.
Which technology segment is growing the fastest?
High-intensity focused ultrasound (HIFU) is expanding at a 5.15% CAGR due to its non-invasive oncology applications.
Why are handheld ultrasound devices gaining popularity?
Handheld units deliver near-cart image quality, cost less, and support telemedicine, enabling wider access in secondary cities and rural areas.
How does reimbursement influence market growth?
New reimbursement codes, such as Brazil’s coverage for histotripsy therapy, improve hospital ROI and hasten adoption of advanced ultrasound systems.
Which country is the fastest-growing market?
Argentina is forecast to grow at a 4.08% CAGR through 2030, powered by public-sector imaging upgrades and rising preventive screening.
What are the main barriers to wider adoption?
Extended regulatory timelines, specialist shortages in non-urban locations, and high equipment costs remain key restraints across the region.
Page last updated on: